Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience

…, J Allendorf, JA Lee, WH Sherman, JA Chabot - Cancer chemotherapy …, 2013 - Springer
Purpose We evaluated the efficacy and safety of capecitabine and temozolomide (CAPTEM)
in patients with metastatic neuroendocrine tumors (NETs) to the liver. This regimen was …

Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics

…, CD Sy, MA Prince, WK Chung, RL Fine, JA Chabot… - Clinical cancer …, 2010 - AACR
Purpose: Pancreatic cancer is a virtually uniformly fatal disease. We aimed to determine if
screening to identify curable neoplasms is effective when offered to patients at high risk. …

An aggressive resectional approach to cystic neoplasms of the pancreas

KD Horvath, JA Chabot - The American journal of surgery, 1999 - Elsevier
Background: Prognosis is good after curative resection for serous and mucinous cystic
neoplasms of the pancreas. There has been a recent trend to resect all cystic neoplasms, without …

Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes

…, P Laise, T Su, A Ahmed, H Hibshoosh, JA Chabot… - Gut, 2019 - gut.bmj.com
Objective Pancreatic ductal adenocarcinoma (PDA) has among the highest stromal
fractions of any cancer and this has complicated attempts at expression-based molecular …

Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection

…, JB Dennison, JP Long, KA Do, J Zhang, JA Chabot… - Gastroenterology, 2021 - Elsevier
Background & Aims There is substantial interest in liquid biopsy approaches for cancer
early detection among subjects at risk, using multi-marker panels. CA19-9 is an established …

Better preservation of endocrine function after central versus distal pancreatectomy for mid-gland lesions

…, EA Yakaitis, JA Lee, BA Schrope, JA Chabot… - Surgery, 2010 - Elsevier
BACKGROUND: Traditional resections for benign and low-grade malignant neoplasms of
the mid pancreas result in loss of normal parenchyma that can cause pancreatic endocrine …

Laparoscopic distal pancreatectomy offers shorter hospital stays with fewer complications

…, PL Reavey, SJ Rosen, JA Lee, JA Chabot… - Journal of …, 2010 - Elsevier
Background Laparoscopic distal pancreatectomy (LDP) is increasingly performed for
lesions of the body and tail of the pancreas. The aim of this study was to investigate short-term …

Thyroidectomy using local anesthesia: a report of 1,025 cases over 16 years

K Spanknebel, JA Chabot, M DiGiorgi… - Journal of the American …, 2005 - Elsevier
BACKGROUND: Thyroid surgery is performed using general anesthesia by the majority of
surgeons in current practice. This study was conducted to analyze the utility and safety of local …

Single-institution experience with irreversible electroporation for T4 pancreatic cancer: first 50 patients

…, EM Hecht, J Susman, JL Weintraub, JA Chabot - Annals of surgical …, 2016 - Springer
Background Irreversible electroporation (IRE) for treatment of locally advanced pancreatic
tumors is garnering increasing attention. This study was conducted to determine perioperative …

Neoadjuvant treatment for pancreatic cancer

AG Raufi, GA Manji, JA Chabot, SE Bates - Seminars in oncology, 2019 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with limited
effective therapeutic options and exceedingly high mortality rates. Currently, cure can only be …